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Electrical activation during atrial fibrillation (AF) appears chaotic and disorganised, which
impedes characterisation of the underlying substrate and treatment planning. While
globally chaotic, there may be local preferential activation pathways that represent
potential ablation targets. This study aimed to identify preferential activation pathways
during AF and predict the acute ablation response when these are targeted by pulmonary
vein isolation (PVI). In patients with persistent AF (n = 14), simultaneous biatrial contact
mapping with basket catheters was performed pre-ablation and following each ablation
strategy (PVI, roof, and mitral lines). Unipolar wavefront activation directions were
averaged over 10 s to identify preferential activation pathways. Clinical cases were
classified as responders or non-responders to PVI during the procedure. Clinical data
were augmented with a virtual cohort of 100 models. In AF pre-ablation, pathways
originated from the pulmonary vein (PV) antra in PVI responders (7/7) but not in PVI non-
responders (6/6). We proposed a novel index that measured activation waves from the
PV antra into the atrial body. This index was significantly higher in PVI responders than
non-responders (clinical: 16.3 vs. 3.7%, p = 0.04; simulated: 21.1 vs. 14.1%, p = 0.02).
Overall, this novel technique and proof of concept study demonstrated that preferential
activation pathways exist during AF. Targeting patient-specific activation pathways that
flowed from the PV antra to the left atrial body using PVI resulted in AF termination during
the procedure. These PV activation flow pathways may correspond to the presence of
drivers in the PV regions.
Keywords: atrial fibrillation mechanisms, catheter ablation, pulmonary vein isolation, computational modelling,
signal processing
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INTRODUCTION
Patients with persistent atrial fibrillation (AF) are a diverse
population. Some patients with persistent AF require multiple
catheter ablation procedures with more extensive ablation
strategies, which may still be ultimately unsuccessful, while
for other patients, isolation of the pulmonary veins (PVs)
is a sufficient treatment approach (Verma et al., 2015).
Identifying appropriate ablation strategies for specific patients
with persistent AF, including stratifying patients for whom
pulmonary vein isolation (PVI) will be sufficient treatment,
remains a clinical challenge (Johner et al., 2019). If solved, this
could lead to improved safety and better patient selection, as
well as decreased time and cost for procedures. Determining the
optimal catheter ablation therapy for patients with persistent AF
requires an understanding of the patient-specific mechanisms
that sustain AF (Calkins et al., 2017).
It can be challenging to characterise mechanisms sustaining
AF because AF appears chaotic and disorganised (Lee et al.,
2014). In particular, the Signal Transfer of Atrial Fibrillation to
Guide Human Treatment (STARLIGHT) clinical study, which
analysed AF complexity from basket mapping catheters, found
no evidence for electrical drivers of persistent AF within the
mapping field and instead demonstrated multiple wavelets
of activation (Child et al., 2018). In the current study, we
hypothesised that while globally chaotic, there may be local
preferential activation pathways that can be identified by
analysing AF activation sequences probabilistically over time.
We further hypothesised that the features of these activation
pathways can be used to predict PVI ablation response.
In this study, we aimed to develop a technique for identifying
preferential pathways of activation by analysing AF wavefront
patterns over time. Then, we aimed to use this information
to predict PVI acute ablation response, with the hypothesis
that in cases where PVI terminated AF during the procedure,
the source of preferential pathways, whether re-entrant or
focal, should originate from the PVs. We performed this
analysis on recordings from patients with persistent AF collected
using simultaneous biatrial contact mapping with 64 electrode
constellation catheters. To test the sensitivity of the algorithm to
driver type, catheter size, and catheter contact, we used synthetic
signals obtained from AF simulations for a virtual patient cohort
in which the underlying AF mechanisms are known.
METHODS
Clinical Basket Recordings
This study assessed 14 patients with persistent AF from the
STARLIGHT clinical trial (NCT01765075) (Child et al., 2018).
These patients had a mean age of 61 ± 8 years, mean duration
of persistent AF of 20.2 ± 6.7 months, mean left ventricular
ejection fraction of 59± 10%, mean left atrium (LA) size of 46×
55mm, and mean right atrium (RA) size of 42 × 55mm. Other
properties are as follows: five patients had hypertension; three
had obstructive sleep apnoea; seven had a body mass index > 30.
All patients gave informed consent and the study was
approved by the local ethics committee. Simultaneous biatrial
contact mapping was performed with two 64 electrode
Constellation catheters (size, 48, 60, and 75mm; Boston
Scientific, Saint Paul, Minnesota), using the Ensite Velocity
cardiac mapping system (St. Jude Medical, St. Paul, MN,
USA). The recordings were performed pre-ablation, post-PVI,
and post each subsequent lesion set. The recordings were
sampled at a rate of 2.0345 kHz and the recording duration
was in the range from 49.8 to 245 s (mean: 147.4 ± 74.6 s).
Acute PVI responders were patients who went into sinus
rhythm or an atrial tachycardia or flutter following PVI,
while acute PVI non-responders remained in AF. Seven of
the patients were PVI responders, six were non-responders
to PVI, and one patient presented with atrial tachycardia,
which provided data for validating the algorithms on a simpler
rhythm. The ablation protocol used isolated the PV first and
secondary lines were only applied if the patient remained in AF
after PVI.
Simulation Data: Constructing a Virtual
Patient Cohort
Imaging data for 25 patients with persistent AF were used to
construct a virtual patient cohort; ethical approval was granted
by the regional ethics committee (17/LO/0150 and 15/LO/1803).
This dataset was a separate clinical imaging cohort from the
STARLIGHT cohort. These cases have a range of atrial sizes
from 90.8 to 244.9 cm2 (mean 143.4 ± 30.5 cm2) and LA
fibrosis surface areas ranging from 5.16 to 46.3 cm2 (mean
20.7 ± 13.5 cm2). We combined different anatomies with
different fibrosis maps from the dataset to create a virtual cohort
of patients, covering the range of atrial sizes, morphologies,
anisotropies, and fibrosis distributions that were seen in patients
with AF (Sim et al., 2019). AF simulations for these models
have different underlying AF mechanisms, cycle lengths, and
arrhythmia complexities. As such, we tested PVI response across
a range of different structural and electrical AF properties.
For each case, the left atrium was segmented from contrast-
enhanced magnetic resonance angiogram (CE-MRA) scans
and registered with late-gadolinium enhancement magnetic
resonance imaging (LGE-MRI) scans using CEMRGApp
software (https://cemrg.com/software/cemrgapp.html) King’s
College London, London, UK (Razeghi et al., 2020). Segmented
meshes were re-meshed to produce a regular edge length
of 0.34mm, using mmgtools software (www.mmgtools.org)
(Dapogny et al., 2014). Simulations were run for monolayer left
atrial models using the Cardiac Arrhythmia Research Package
(CARPentry) simulator, with the monodomain model for
excitation propagation and the Courtemanche-Ramirez-Nattel
human atrial ionic model (Courtemanche et al., 1998), and with
modifications to represent the effects of AF electrical remodelling
(Courtemanche et al., 1999; Vigmond et al., 2003). Longitudinal
conductivity was assigned as 0.4 S/m and transverse as 0.1 S/m
(Bayer et al., 2016). Models were constructed with repolarization
heterogeneity by labelling each PV and the LA appendage using
Paraview software, Kitware (https://www.paraview.org/) and
assigning different ionic conductances, following our previous
studies (Roney et al., 2018, 2019). Fibrotic remodelling was
incorporated in each mesh according to the LGE-MRI intensity
values, which were assigned as the maximum value through the
wall (Sim et al., 2019).
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Fibrotic effects were incorporated as regions of conduction
slowing [100% conduction velocity (CV) in regions of 0–56%
normalised LGE intensity, 80% CV for 56–60% LGE; 60% CV
for 60–64% LGE, and 40% CV for > 64% normalised LGE
intensity]. The ionic properties were also modified in fibrotic
regions to represent the effects of elevated TGF-β1 (maximal
ionic conductances were rescaled in regions with LGE intensity
> 3 standard deviations above the mean of the blood pool as
follows: 50% gK1, 60% gNa, and 50% gCaL) (Roney et al., 2016;
Zahid et al., 2016; Krueger et al., 2014).
Simulations were run for each anatomy, with or without
patient-specific fibrosis and with two further different fibrosis
maps randomly selected from the remaining 24 fibrosis maps
to create a virtual patient cohort of 100 models. These 100
models were used for testing the preferential pathways analysis
algorithms. Fibrosis distributions were mapped between atrial
anatomies by expressing all anatomies in universal atrial
coordinates, following our previous methodology (Roney et al.,
2019).
To investigate the effects of fibre field on simulated
preferential pathways and PVI acute response, fibrosis model
simulations with three different fibre fields were compared. The
baseline fibre field incorporated in all model set-ups (the 100
models described above) was the rule-based LA endocardial fibre
field in the study of Labarthe et al. (2014). Additional simulations
were performed for the 25 different anatomies incorporating
patient-specific fibrosis with a diffusion tensor MRI (DTMRI)
human atrial fibre field (dataset number 1 from Roney et al.,
2020b) or an average LA endocardial field constructed from seven
DTMRI datasets (Roney et al., 2020b available to download at
https://zenodo.org/record/3764917). For each case, atrial fibres
were mapped to each atrial mesh using the universal atrial
coordinate system (Roney et al., 2019).
Simulation Data: AF Initiation,
Post-processing, and Modelling PVI
Ablation
Atrial fibrillation was induced through burst pacing, and basket
catheter electrode signals were simulated across the atria, as
shown in Figure 1. For each model, AF was induced through
burst pacing the right superior pulmonary vein (RSPV) at a
cycle length of 155ms for five beats following sinus rhythm
(Roney et al., 2018). To investigate the effects of AF initiation
pacing protocol on preferential pathways and PVI outcome, we
considered two additional pacing protocols for the 25 models
with patient-specific fibrosis and the rule-based LA endocardial
fibre field (Roney et al., 2020a). These methods and results are
presented in detail in the Supplementary Material.
Atrial fibrillation transmembrane potential data were analysed
at points that correspond to a constellation basket catheter
configuration, using the same methodology that was used
for the clinical data. Our previous study compared simulated
unipolar electrogram phase and bipolar electrogram phase to
action potential phase to demonstrate a good agreement (phase
singularity trajectory distance < 0.8mm) (Roney et al., 2017b).
To construct a basket arrangement of points in each anatomy,
the recording locations from one of the clinical cases were aligned
with a simulation mesh such that the largest separation between
splines was across the mitral valve annulus (see Figure 1). These
locations were then rescaled by two scaling factors to represent a
larger and smaller basket and assigned to the closest points on the
atrial geometry. Finally, to transfer the basket electrode locations
to each atrial geometry, electrode locations were expressed in
universal atrial coordinates (Roney et al., 2019) and mapped to
the corresponding atrial coordinates on the target anatomy.
Pulmonary vein isolation, which was modelled as two non-
conducting rings (tissue conductivity of 0.001 S/m) around the
left and right LA-PV junctions, was applied 5 s post-AF initiation
for all AF simulations. Pulmonary vein isolation outcome was
visually classified at 2 s post-PVI as responder (macro-reentry or
termination) or non-responder (AF continues).
Simulation Data: Biatrial Bilayer
Simulations of Different Atrial Rhythms
To test the preferential pathways methodology on different atrial
rhythms, we used simulation data from a previously published
biatrial bilayer model (Labarthe et al., 2014). Left and right atrial
baskets were positioned in each atrium by rescaling, rotation, and
translation of clinical basket electrode locations. Atrial flutter was
initiated by applying a line stimulus from the tricuspid valve to
the inferior vena cava and temporarily adding a line of the block
along the crista terminalis. After five re-entry circuits, this line of
the block was removed and the re-entry was sustained. The focal
activity was simulated by stimulating a region on the posterior
wall of the left atrium at a cycle length of 200 ms.
Electrogram Processing
Unipolar electrogram signals were processed to calculate a
normalised derivative signal and a phase signal using a
sequence of steps, shown in Supplementary Figure 1. First, QRS
subtraction was applied to unipolar electrograms to remove any
ventricular artefacts from the signals (Shkurovich et al., 1998).
Following QRS subtraction, electrograms were differentiated and
the derivative signal was filtered using a sequence of filters
typically used prior to dominant frequency analysis to make
the signal more sinusoidal (Ng et al., 2007). For each of the
64 electrodes on each basket catheter, filtered derivative signals
were normalised and the unipolar phase was also calculated,
following our previously validated methodology (Roney et al.,
2017b) (for further details see the Supplementary Material). The
mean cycle length (CL) was calculated for each electrogram by
taking the mean of all the time intervals between peaks of the
normalised filtered derivative signal. The mean of all LA or RA
electrogram CLs was calculated to give the mean LA or RA CL
for each patient.
Normalised filtered derivative signals were then displayed
in a 9 × 8 arrangement corresponding to the eight splines of
the basket catheter, which each have eight electrodes, with the
anterior mitral valve (MV) spline duplicated at the posterior MV
side of the grid, following the study of Child et al. (2018) (see
Figure 2). The visualisation used has the posterior MV at the
bottom of the grid, the anterior MV at the top, and the left PV
(lateral wall) and right PV (septal wall) on the left and right
of the grid, respectively. Correspondingly for the right atrium
(RA), the inferior vena cava (IVC) is displayed at the bottom
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FIGURE 1 | Schematic showing the steps in model construction, simulation, and post-processing. (A) Imaging data were segmented, and simulation meshes were
created incorporating conductivity and ionic changes in areas of fibrotic tissue identified using LGE-MRI intensity values. Atrial fibrillation (AF) was simulated and
analysed at a basket arrangement of points modelled based on clinical electrode locations. Pulmonary vein isolation (PVI) was applied after 5 s. (B) Models were
generated for different combinations of anatomy and fibrosis distribution to build a virtual patient cohort of 100 models. (C) Simultaneous biatrial contact mapping was
performed with two 64 electrode Constellation catheters.
of the grid, the superior vena cava (SVC) at the top, the septal
tricuspid valve (TV) on the left, and the lateral TV on the right.
This 2D arrangement was performed on a case-by-case basis
depending on the spline arrangement in relation to the MV and
TV location. Finally, these data were linearly interpolated to a
higher resolution grid with an additional two points introduced
between every two points on the original grid (Roney et al.,
2017a).
Vector Mapping, Streamline Visualisation,
and Statistics Over Time
To track the direction of propagation of activation wavefronts,
the optical flow of the interpolated grid of normalised filtered
derivative signals was calculated. Specifically, a displacement
vector was calculated for each normalised filtered derivative
pixel at each time frame analysed to show where that pixel is
found in the next time frame, i.e., the direction of flow. This
was performed at an increment of 40 frames (approximately
20ms) to allow for sufficient movement of pixels between frames.
This implementation followed Horn and Schunck (1981). These
optical flow vectors were then averaged for activation wavefronts,
which were identified as isolines of 0.9 normalised filtered
derivative with greater than three connected pixels (Kay andGray
et al., 2005), as shown in Figure 2. This averaging was performed
over 10 s windows using vector addition.
For visualisation of these average optical flow vectors and
identification of preferential pathways, activation streamlines
were constructed. Activation streamlines were calculated using
an adaptation of the technique as proposed in the study
of Saliani et al. (2019). Specifically, a Delaunay triangulation
of the recording points was calculated to construct a mesh,
and streamlines were initially calculated from seeds at each
mesh element. This construction progressed both forward
and backward along the vector field direction, subject to an
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FIGURE 2 | Methodology used for calculating the average activation flow vector field from unipolar electrograms. (A) The normalised filtered derivative signal for each
electrode on the basket catheter was displayed in a regular 9 × 8 grid. These signals were interpolated to a higher resolution grid, and optical flow vectors were
calculated. The vectors were averaged over time for isolines of constant normalised filtered derivative signal (indicated by white and black dots; wavefront and wave
back). Finally, streamlines were calculated from average optical flow vectors to visualise activation pathways. The normalised derivative, interpolate and isoline plots
are snapshots representing the wavefronts at a given time in the recording, while the average activation flow and streamlines are calculated as an average across the
10 s recording. (B) Example PV activation flow calculation for a case with low PV activation flow. Vectors within the blue boxes were assessed, with red vectors tagged
as PV antra to LA activation flow. (C) Example PV activation flow calculation for a case with high PV activation flow.
angular stopping criterion of 0.7 radians. Finally, a set of these
streamlines was built iteratively at the desired spacing by adding
streamlines to the set by order of decreasing streamline length
subject to a minimum distance criterion (0.5 pixels). Each
streamline is plotted with thickness dependent on the magnitude
of the underlying average vector field to indicate how often
a direction is repeated. The direction of the centre of each
streamline is marked with an arrow, again with magnitude
proportional to the magnitude of the average vector field
at that point. An example is shown in the final subplot of
Figure 2.
To quantify the degree of PV antra to LA body activation
flow, the percentage of optical flow vectors that were of threshold
magnitude and directed into the LAwere calculated. This analysis
was performed for vectors within a box close to the left PV and
a box close to the right PV, indicated in blue in Figures 2B,C.
Specifically, vectors within these boxes were tagged as PV to LA
activation flow in the case that their magnitude was larger than
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the mean magnitude across the array to represent a degree of
repeatability, and that their direction was within a 90◦ range into
the body. These vectors were identified for both the left PV and
the right PV antra, and an activation flow metric was calculated
for each box separately as the percentage of all vectors in the
boxes tagged as representing PV to LA activation flow. The PV
activation flow metric was then calculated as the maximum of
the left PV and right PV activation flow metrics. To compare
PV activation flow metrics between PVI responders and PVI
non-responders, we performed the Wilcoxon signed-rank test
and calculated the following metrics: sensitivity; specificity; area
under the receiver operating characteristic curve.
Calculation of vector maps and activation flow maps was
performed blinded to acute PVI response.
RESULTS
Testing on Simulated Atrial Re-entry and
Focal Activation
Simulations of atrial re-entry and focal activation resulted in
activation flow patterns that qualitatively reflected the underlying
activation, as shown in Figure 3 for the biatrial bilayer model.
Simulation data corresponding to an RA atrial flutter is shown in
Figure 3A with wavefront propagation from the IVC along the
septal wall to the RAA and SVC, which then propagated along
the lateral wall from the RAA and the SVC to the IVC. This
wavefront propagation, from the IVC to SVC along the septal
wall and from the SVC to IVC along the lateral wall, has formed
a re-entrant circuit.
The activation streamlines constructed from the average
optical flow field vector map show this activation pattern, with
the wavefront propagation direction indicated by the green
arrows. A re-entrant pattern is visible on the roof of the right
atrium because there is a driving pattern around the TV that
propagated along the septal wall from the IVC to SVC, and
then along the lateral wall from the SVC to the IVC. This
resulted in the discontinuity in the streamlines along the roof
as one end of the reentrant wavefront travels along the roofline
and did not propagate to the other wall as it is still refractory
from the previous propagation. A further simulation example
representing a fixed focal source is shown in Figure 3B, with
an activation streamline map that is divergent from the source
location. This demonstrated that the methodology correctly
identifies re-entrant and focal mechanisms.
Testing on Clinical Atrial Tachycardia Data
To validate the developed algorithms on clinical data, we
applied the techniques to a typical clinical tachycardia case.
Macro-reentrant tachycardia generated a regular activation,
which should manifest as clear lines following the activation
path, providing suitable data for validating our algorithms.
Clinical atrial tachycardia data for one patient with re-entry
on the posterior LA wall and passive RA activation, previously
analysed in the study of Child et al. (2018), were used to
test our preferential pathways methodology. Figure 4A shows
phase maps for the unipolar electrogram recordings, together
with the normalised filtered derivative signals interpolated to
a regular grid on which re-entry on the posterior LA wall is
observed and regular passive RA activation. Streamlines that
were constructed from the average optical flow activation vector
fields for this case had demonstrated a re-entrant activation
pattern on the LA posterior wall and regular RA activation
starting at the septal RA wall following activation from the LA,
offering testing of the technique. Figure 4B shows LA basket
electrograms at four locations indicated by the locations E1–E4.
These electrograms are sequentially activated, demonstrating the
presence of re-entry.
Testing on Simulated AF Data: Pathway
Analysis and PV Activation Flow Metrics
for PVI Responders vs. Non-responders
Preferential pathway analysis was next applied to simulated pre-
ablation AF recordings across the cohort of 100 models. AF was
initiated in the same way for each model through burst pacing
the RSPV, while maintenance mechanisms varied between the
models, exhibiting different numbers, stability, and locations of
drivers. Figure 5A shows example simulated isopotential maps
for AF pre-ablation for a case in which PVI terminated AF,
and Figure 5B shows an AF example pre-ablation in which AF
continued post-PVI. For the PVI responder case (Figure 5A),
re-entry around the right PV drove the AF pre-ablation, with
secondary rotational activity and break-up below the left inferior
pulmonary vein (LIPV) in an area of fibrotic remodelling. It is
challenging to determine the dominant arrhythmia driver from
the isopotential maps, but right PV driver dominance was evident
on the average optical flow activation map, for which 22% of
PV vectors represented activation flow from the PV antra to the
LA body. For the PVI non-responder case (Figure 5B), there
were multiple drivers in the LA body pre-ablation as well as
break-up due to fibrosis, with no clear drivers in the PV regions.
The optical flow map is more chaotic, with only 4% of PV
vectors representing PV activation flow. Splitting the pre-ablation
simulations into PVI responder and non-responder cases results
in significantly different PV activation flow metric values, shown
in Figure 5C. The results are as follows: median for responder
21.1% vs. non-responder 14.1%; p = 0.018 (Wilcoxon signed-
rank); sensitivity = 0.79; specificity = 0.58; area under the
receiver operating characteristic curve= 0.69.
Fibre field does not have a large impact on simulated acute
response or PV activation flow metric in models incorporating
fibrotic remodelling (86.7% of model PV activation flow metrics
for the two fibre fields were within ±10% of baseline fibre field,
see Supplementary Material). These simulations were for the
25 anatomies with patient-specific fibrosis with three different
fibre field maps. Overall, this provided a confirmation of the PV
activation flow metric for a virtual patient cohort.
Application to Clinical AF Data: Pathway
Analysis and PV Activation Flow Metrics
for PVI Responders vs. Non-responders
Vector maps calculated on pre-ablation clinical recordings for
PVI responder cases are shown in Figure 6. These maps visually
demonstrated preferential flow from the PV antra regions, which
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FIGURE 3 | Validation using simulated data: flutter and focal activity. (A) Simulated atrial flutter with activation streamlines from the IVC to SVC along the septal wall
and from the SVC to IVC along the lateral wall, to complete the re-entry circuit. Basket location, isopotential plots and the activation streamlines are shown. The
wavefront propagation path direction is indicated by the green arrows. The orientation of the RA in each sub-figure was chosen to offer easier visualisation of the
electrode locations and the wavefront propagation direction. (B) A simulated repetitive focal source manifests as a divergent activation streamline field. TV, tricuspid
valve; SVC, superior vena cava; IVC, inferior vena cava; RAA, right atrial appendage; MV, mitral valve; LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary
vein; RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein; LA, left atrium; RA, right atrium.
were marked as left inferior PV (LIPV), left superior PV (LSPV),
right inferior PV (RIPV), and RSPV, into the atrial body. The
activation of the atrial body from the PV regions was quantified
using the PV activation flow metric. In the pre-ablation cases
shown in Figure 6, this was 37.5, 28.8, 26.9, 16.4, 12.5, 10.6,
and 5.8%. Conversely, pre-ablation recordings for which PVI
ablation did not terminate AF, as shown in Figure 7, did not
visually demonstrate a preferential activation flow from the PV
antra into the atrial body. Instead, recordings demonstrated a
range of repeatability over time: some recordings exhibited the
presence of repeated re-entrant activity within the atrial body,
while others were more chaotic. The pulmonary vein activation
flow metric for these cases pre-ablation are as follows: 0, 1.9, 2.9,
4.5, 6.7, and 27.9%. The average optical flow vector fields with
PV activation flow vectors indicated in red are shown for PVI
responders in Supplementary Figure 2 and PV non-responders
in Supplementary Figure 3.
Figure 8A shows that for the clinical dataset, the PV activation
flow pre-ablation was significantly higher for PVI responders
than PVI non-responder cases. The results are as follows: median
16.3 vs. 3.7%; p = 0.035, (Wilcoxon signed-rank); sensitivity
= 0.86; specificity = 0.83; area under the receiver operating
characteristic curve = 0.86. Other metrics including LA cycle
length (Figure 8B: median 182ms for PVI responder, 173ms for
PVI non-responder) and RA cycle length (Figure 8C: median
183ms for PVI responder, 176ms for PVI non-responder) were
not significantly different between the PVI responder and non-
responder groups.
Algorithm Sensitivity to Recording Window
Choice and Duration Assessed Using
Clinical Recordings
To test the effects of recording duration onmeasured preferential
pathways, average optical flow maps were constructed and
the PV flow metric was calculated for one clinical case using
between 5 and 120 s of data (with 5 s increment). The pulmonary
vein flow metric was within a small range of 35–40.4%, and
so did not depend on recording duration. We also tested
whether the choice of 10 s segment used for analysis from
the AF episode affected the PV flow metric by analysing 10
intervals of 10 s spaced at regular intervals through an AF
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FIGURE 4 | Algorithm validation using clinical atrial tachycardia data. (A) Clinical atrial tachycardia phase maps, exhibiting re-entry on the LA posterior wall and
passive RA activation are shown on the left of the figure. Normalised filtered derivative signals interpolated to a regular grid are shown on the top right for a single time
point to show LA re-entry. Streamlines constructed from the average optical flow activation field for this clinical atrial tachycardia case demonstrate a re-entrant
activation pattern on the LA posterior wall, and regular RA activation starting at the RA septal wall as it is activated from the LA. (B) Four LA basket electrograms are
shown at the grid locations indicated by boxes with E1 to E4 on the streamline map. Locations E1-E4 are sequentially activated, demonstrating the presence of
reentry. TV, tricuspid valve; SVC, superior vena cava; IVC, inferior vena cava; RAA, right atrial appendage; MV, mitral valve; LSPV, left superior pulmonary vein; LIPV, left
inferior pulmonary vein; RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein; LA, left atrium; RA, right atrium.
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FIGURE 5 | Simulated data PV activation flow metric is significantly different for PVI responder and non-responder cases. Isopotential snapshots (left), streamlines
(middle), and optical activation flow (right) plots for examples of (A) PVI responder and (B) PVI non-responder. PV activation flow was quantified as % of vectors
pointing into the LA body in a 90◦ range within the PV regions (blue boxes). PV activation flow vectors are shown in red. (A) For this simulation, re-entry around the
right PV drives AF pre-ablation and PVI terminates AF (an example of a responder), with a PV activation flow metric of 22.2%. (B) For this simulation, multiple drivers
exist in the LA body pre-ablation, and PVI did not terminate AF (an example of a non-responder); the PV activation flow metric is 4.4%. (C) Simulated PV activation
flow metric is significantly different pre-ablation for PVI responder and non-responder cases (median 21.1 vs. 14.1%, p = 0.018, Wilcoxon signed rank).
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FIGURE 6 | Clinical average vector fields demonstrate activation flow from the PV antra into the atrial body for PVI responder cases pre-ablation. Paths are shown for
the left and right atria as streamlines with the magnitude dependent on the magnitude of the underlying average vector field, signifying how often a direction is
repeated. The direction of the centre of each streamline is also indicated. Cases are arranged in order of decreasing PV activation flow metric: (A) 37.5%, (B) 28.8%,
(C) 26.9%, (D) 16.4%, (E) 12.5%, (F) 10.6%, and (G) 5.8%.
recording. Figure 9 shows example activation streamline maps
for different recording segments within a single AF episode.
This example AF recording was 217.8 s, and so all intervals
represent separate segments with no overlap (approximately
20 s between the start of each interval). For this example, 9
out of the 10 intervals which were assessed had demonstrated
visually similar activation, with PV activation flow metric within
±10% of the first interval. Preferential activation pathways were
seen from the right PV antra to the LA body for nine of the
recordings (for example Figures 9A,C,D), while one interval
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FIGURE 7 | Clinical average vector fields did not demonstrate activation flow from the PV antra into the atrial body for PVI non-responder cases pre-ablation.
Visualisation details are as in Figure 6. Cases are arranged in order of increasing PV activation flow metric: (A) 0, (B) 1.9, (C) 2.9, (D) 4.5, (E) 6.7, and (F) 27.9%. For
case (D), multiple splines of the LA basket were not in contact and so these were excluded from the analysis.
instead demonstrated flow from the left PV antra to the LA body
(Figure 9B).
Comparing the PV activation flowmetric for the 10 s segments
to the PV activation flow metric for the first window across all
clinical cases, showed that 79.2% of PV activation flow metrics
for the different windows were within ±10% of the first window
(77.1% for PVI responders and 81.7% for PVI non-responders).
Algorithm Sensitivity to Catheter Size and
Contact Tested Through Simulations
This study further investigated the effects of basket size and
contact on the preferential activation flow calculation and the PV
activation flow metric using simulation. Decreasing the basket
size from an average spline length of 50 to 35.7mm for the
same simulation set as in section Testing on Simulated AF
Data: Pathway Analysis and PV Activation Flow Metrics for
PVI Responders vs. Non-responders resulted in a PV activation
flow metric difference that is no longer significant (larger basket:
median 21.1 vs. 14.1%, p= 0.018, Wilcoxon signed-rank median;
smaller basket: 24 vs. 17.7%, not significant, see Figure 10). This
demonstrated that catheter coverage is important, as well as
recording distance from the PVs. The baseline simulated basket
size was similar to the smallest of the clinical baskets (simulated:
50mm; clinically used basket sizes were 48, 60, and 75 mm).
Our current methodology assumes basket recordings are
located on a regular grid. However, for catheter recordings in
patients, inter-spline distances vary. The study of Laughner et al.
(2016) showed that inter-spline distances exhibit large variations
for basket catheters, depending on deployment. In addition,
multiple studies have shown that spatial resolution affects the
analysis of arrhythmia mechanisms (Roney et al., 2017a). To test
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FIGURE 8 | The clinical PV activation flow metric is significantly different for PVI responder and non-responder cases. (A) Clinical PV activation flow (%) pre-ablation
was significantly higher for PVI responder than PVI non-responder cases (PVI responder: 16.3% vs. non-responder: 3.71%, p = 0.035). (B) LA cycle length was not
significantly different between groups (Wilcoxon signed-rank). (C) RA cycle length was not significantly different between groups.
FIGURE 9 | Effects of recording duration on streamlines for example AF episode. Streamlines are shown for 10 s recordings taken from intervals spread through the
entire recording. The top row shows the left atrium, and the bottom row shows the right atrium. The streamline plots in (A) show the original interval; panels (C,D) are
visually similar to (A), while the LA for (B) demonstrates larger differences. The PV activation flow metrics from the right PV are as follows: (A) 37.5%, (B) 96%, (C)
31.7%, (D) 38.5%. There were 9 out of 10 recordings that had no activation flow from the left PV to the LA body, while (B) has a PV activation flow metric from the left
PV of 27.3%. The start times for these recordings are 0, 6, 125, and 187 s.
these effects on our current analysis, we simulated the effects
of removing electrode recordings from the analysis across the
100 atrial models. The effects of poor electrode contact were
simulated by randomly removing electrogram recordings from
the analysis across all simulations. The percentage of points
removed was varied in the range of 10–50%. The pulmonary vein
activation flow metric was higher for PVI responder cases than
for PVI non-responder cases when the analysis was performed
with all electrodes, 90 or 75% of electrodes, although these
differences were only significant for the case of all electrodes. It
was not possible to differentiate between the PVI responder and
PVI non-responder groups when only 50% of electrodes were
included in the analysis; shown in Figure 11.We next considered
that electrode locations in poor contact are likely to be spatially
correlated, and so we considered randomly removing one spline,
two splines, or four splines of data from the analysis. These
results are shown in Supplementary Figure 4. As for the case of
randomly removing electrodes, the PV activation flowmetric was
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FIGURE 10 | Effects of basket size on preferential pathways. Reducing the basket size changed the significance of the PV flow metric: larger basket: median 21.1 vs.
14.1%, p = 0.018, Wilcoxon signed-rank median; smaller basket: 24 vs. 17.7%, not significant.
higher for PVI responder cases than for PVI non-responder cases
when the analysis was performed with all splines, one missing
spline or twomissing splines. For the case of four missing splines,
i.e., only 50% of electrodes included, it was again not possible to
differentiate between the two groups.
Algorithm Sensitivity to Driver Type Tested
Through Simulations
We tested if the mechanistic source of PV activation flow affected
our results. In doing this, simulated cases without fibrosis for
which PVI terminated AF (n = 6) were selected from the dataset
and simulated AF pre-ablation was compared with simulating a
repeated PV trigger (through pacing the RSPV at 155ms for 5
beats). The left side of Figure 12 shows examples (Figure 12A)
isopotential maps, (Figure 12B) average optical activation flow
vector fields, and (Figure 12C) activation streamlines for a
simulation sustained by PV triggers. In this case, preferential
activation flow is from the PV antra to the LA body and the PV
activation flowmetric is 31.7%. The right side of Figure 12 shows
the same anatomy but for a simulation where re-entry around the
PV antra drives AF, with a PV activation flow metric of 25.5%.
The streamline map for the PV trigger case is more organised
than the streamline map for the PV rotational driver. Collating
the simulations, the PV activation flowmetric for PV triggers and
PV re-entry cases are not significantly different (mean triggers: 26




In this study, we proposed and tested amethodology for detecting
preferential activation pathways in patients with persistent AF.
We tested the methodology on simulated data and a clinical
atrial tachycardia dataset. The technique developed in this study
identified patients likely to respond to PVI during the ablation
procedure as those with preferential activation flow from the
PV antra to the left atrial body. We hypothesised that this
activation flow may correspond to the presence of drivers in PV
regions. We simulated AF sustained by either PV triggers or
by PV rotational drivers to demonstrate that both mechanisms
result in a similar PV flow metric. As such, this suggested that
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FIGURE 11 | Effects of basket contact on preferential pathways. Effects of poor contact on preferential pathway analysis. PV activation flow metrics are shown for
cases with 10–50% of electrodes removed. (A) All electrodes: median 21.1 vs. 14.1%, p = 0.018, Wilcoxon signed rankmedian. (B) 90% of electrodes included: 17.9
vs. 11.9%, p = 0.07. (C) 75% of electrodes included: 16.7 vs. 10.3%, p = 0.09. (D) 50% of electrodes included: 6.4 vs. 10.7%, p = 0.49.
isolating the PV antrum is more important in some patients than
others when the mechanism for maintaining persistent AF in
the atria has preferential pathways using the area around the
PVs. Our study could motivate a prospective clinical study to
confirm the relationship between preferential flow and long-term
PVI outcome.
Comparison to Other Methodologies
Phase mapping for this dataset did not identify stable
rotational activity (Child et al., 2018), suggesting anarchic
fibrillation. Instead, analysing these data probabilistically over
time identified preferential pathways of activation, indicating a
degree of hierarchy.
Our preferential pathway technique has identified repeated
structures in the activation patterns. The study of Vandersickel
et al. proposed a directed network for identifying repeated
activation patterns in the specific case of tachycardia arrhythmias
(Vandersickel et al., 2019). Their technique worked on atrial
surface meshes rather than projecting to a two-dimensional
grid, but this requires a higher resolution data set. Both
approaches determine likely circuits of activation. On one hand,
the directed network approach in the study of Vandersickel et al.
(2019) assumed a stable re-entry circuit, for example, an atrial
tachycardia (Van Nieuwenhuyse et al., 2021). On the other hand,
our technique also worked for fibrillatory data. As such, we have
proposed a novel general tool for identifying critical paths of
activation during atrial arrhythmia, which can be applied to atrial
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FIGURE 12 | Simulating PV triggers vs. PV rotational drivers. (A) Isopotential plots, (B) average optical flow activation vector fields and (C) activation streamlines are
shown for a case sustained by PV triggers (left) and for a PV rotational driver (right).
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macro-reentrant tachycardia (Figure 4) or fibrillation (Figures 6,
7). Similarly, the study of Bellmann et al. (2018) has published
an electrographic flow mapping technique to identify electrical
sources within the mapping field and classify them as either
active or passive. Our technique could be used similarly, but
we found no evidence of drivers in the mapping field in this
patient cohort. Instead, we utilised the activation flow direction
to identify preferential pathways and to assess the arrhythmia,
in which we hypothesised that PV triggers or drivers exist for
cases in which activation flow occurred from the PV antra to the
LA body (Figure 6). Our current methodology assumed global
biatrial recordings, and our future work will aim to adapt this
technique to work with sequentially acquired data, with a focus
on recording at the PV antra.
Relation to Other AF Mechanisms
Our study demonstrated the importance of activation from the
PV in predicting acute PVI response, wherein PVI responder
cases had a significantly higher PV activation flow metric pre-
ablation than PVI non-responder cases (Figure 8). Similarly, the
study of Navara et al. (2018) demonstrated using two mapping
methodologies (Rhythmview from Abbott and phase mapping)
rotational activity and focal activity in PV antral regions in
patients for whom AF terminated during the PVI procedure,
which would manifest as preferential activation flow from the
PV antra to the LA body. These results agree with our findings.
For cases in which activation flow was from the PV antra to
the LA body, we found that this was from either the left or
right PV, and the utilised PV did not change over time. Previous
studies have hypothesised that the smooth PV antra may act as
an anchor for rotors (Hocini et al., 2002), which agrees with our
simulation studies. Our previous simulation study showed that
high PV phase singularity density may indicate the likelihood of
a positive PVI response (Roney et al., 2018). Our current study
extended our previously proposed metric to one that does not
require PV recordings, greatly increasing clinical applicability.
Our current simulations suggested that clinical basket sizes are
sufficient for PVI ablation outcome prediction using the PV
activation flow metric (Figure 10). The simulations also showed
that the PV activation flow metric cannot differentiate between
PV triggers and PV rotational drivers using LA body recordings
alone (Figure 12). Although this distinction is mechanistically
important, the PVI outcome is the same in either case.
The examples shown in Figure 6G (PVI responder) and
Figure 7F (PVI non-responder) represent outliers. For the PVI
responder case (Figure 6G), the optical flow vectors (shown in
Supplementary Figure 2G) visually demonstrate flow from the
right PV antra to the LA body. However, the magnitudes of these
vectors were less than the mean magnitude and so these did not
count toward the PV activation flow metric. In this case, the
activation flow away from the PV demonstrated a high degree
of repeatability. Modifying the threshold magnitude for when to
include activation vectors in the PV activation flow metric would
increase the value for this outlier. In contrast, the magnitude of
repeated directions across the basket device is small for the PVI
non-responder case (Figure 7F and Supplementary Figure 3F).
For this case, the PV activation flow metric is high even though
PV activation flow is not visually evident on the activation
streamline map, due to the small vector magnitude in the LA
body. It is possible that PV isolation was incomplete for this
patient resulting in AFmaintenance post-PVI ablation. The other
PVI non-responder cases in Figure 7 demonstrated preferential
paths in the LA body, distinct from any PV activation flow.
The study of Dharmaprani et al. (2019) characterised AF
dynamics through calculating the lifetimes of wavelets and
phase singularities demonstrating exponential lifetimes, which
was also seen in the study conducted by Child et al. (2018).
Our current study demonstrated preferential flow from the
PV antra when activation directions were averaged over time.
This is compatible with an exponential distribution of phase
singularity lifetimes, suggesting that wavefront propagation may
demonstrate preferential directions over time.
An alternative AF sustaining mechanism is the presence of re-
entry in the RA. For example, the study of Hansen et al. (2015) has
demonstrated the presence of intramural re-entry along fibrotic
tracks in the human RA. These re-entries were detectable using
sub-endocardial mapping for 80% of re-entries, but only for 40%
of sub-epicardial re-entries, using FIRM mapping (Zhao et al.,
2017). We did not find any evidence of such RA re-entries in this
patient cohort using our methodology.
Simulation Limitations
We used a monolayer model for the simulations in this study.
The monolayer is an approximation, like all models, of the
atrial activation patterns observed clinically. We chose to use
a monolayer model as its complexity reflected the available
data. While wall thickness and transmural fibrosis distribution
may contribute to atrial arrhythmias and ablation outcomes
(Csepe et al., 2017; Roy et al., 2018; Ali et al., 2019), these
cannot be reliably measured using standard clinical LGE-MRI.
We did not account for these features, and this is an inherent
limitation of building models from routine clinical data. The
AF simulations in this study were initiated through pacing the
RSPV. To investigate the effects of AF initiation protocol on
preferential pathways and the PV activation flow metric, we
also simulated AF initiation through burst pacing the LSPV or
using initial conditions corresponding to four spiral wave re-
entries. We found that the AF initiation pacing protocol used
affected the preferential pathways and PV activation flow metric,
where AF wavefront patterns were generally different for AF
initiated using each of the AF initiation protocols for the same
model (see Supplementary Figure 5). Despite this, it was still
the case that the PV activation flow metric was higher for PVI
responders compared with non-responders: for LSPV pacing:
15.6 vs. 5.3% (p = 0.06) and for initiation with four spiral wave
re-entries: 19.6 vs. 9.6% (p = 0.03). These results are presented
in the Supplementary Material. Our future work will extend
this to systematically investigate the effects of initiation location
on preferential pathways and will test this metric for different
AF induction protocols (for example, following the studies of
Azzolin et al., 2021 and Boyle et al., 2018).
To test whether the PV activation flow metric defined in this
study could be used to predict acute PVI response in simulations,
we post-processed transmembrane potential signals from AF
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simulations. Similar to the previous studies (Boyle et al., 2018;
Roy et al., 2018; Azzolin et al., 2021), we chose to analyse
transmembrane potential signals to eliminate the complexities
associated with the effects of wavefront direction on electrogram
complexity. However, to demonstrate the full applicability of our
pipeline in the clinical environment, it is necessary to also test it
on electrogram signals. To test whether the choice of the signal
used to calculate preferential pathways affected our simulation
results, we compared PV activation flow metrics calculated
using transmembrane potential signals to those from unipolar
electrogram signals for the LSPV paced dataset. These results are
presented in the Supplementary Material where we found that
the PV activation flow metric for unipolar signals was similarly
higher for PVI responders compared with non-responders, with
the same significance value as for the transmembrane potential
analysis (p= 0.06 for both data types). This suggested themethod
was not significantly affected by the choice of the input signal,
agreeing with our previous study (Roney et al., 2017b). However,
these simulations do not include the effects of several clinical
complexities, including electrode size, orientation, and noise on
the electrogram signals (Potse, 2018).
A further analysis choice or assumption is how to treat data at
the mitral and tricuspid valves. We chose to follow the study of
Child et al. (2018) and duplicated the anterior MV spline at the
posterior side of the grid (using a similar approach for the TV),
working on a 9 × 8 grid. This captured that there may be areas
where propagation occurred across these splines. An alternative
approach was to work on an 8 × 8 grid (Narayan et al., 2012).
To test the effects of grid choice, we compared the PV activation
flow metric for an 8 × 8 grid to the default 9 × 8 grid analysis.
This analysis is presented in the Supplementary Material. Using
an 8× 8 grid, the PV activation flow metric was also significantly
higher for the PVI responder cases with a p-value of 0.012 (21.4
vs. 14.0%), similar to the results for the 9 × 8 dataset (21.1 vs.
14.1%, p= 0.018). The difference between activation flowmetrics
calculated with or without spline duplication was small, with a
mean absolute difference of 1.4%.
Clinical Limitations
This study has further limitations clinically. We had applied
a new method to a limited number of patients in an acute
study. The proportion of acute PVI responders is likely to be
different in a larger patient population (Verma et al., 2015). A
limitation of this study is that patients did not receive the same
ablation procedure. All patients had PVI at the start of their
ablation, but subsequent ablations were at the discretion of the
operator. This was accounted for by assessing acute PVI ablation
outcome during the procedure, which while correlated with long-
term outcome, is not a surrogate for a long-term outcome (Lim
et al., 2015; Kochhäuser et al., 2017; Singh et al., 2017). This
study motivated the application of this technique to a larger
patient cohort in a prospective trial with standardised ablation
procedures and long-term follow-up to determine applicability
for general clinical practise. Temporally averaging and spatially
coarsening the data to calculate preferential pathways may lose
information on individual wavefronts. The technique presented
here could be extended to assess the role of the left atrial
appendage (Romero et al., 2020), and to identify the intermittent
driver or focal regions by analysing shorter recording segments
(Gerstenfeld et al., 1992). Future work will compare pathways
to atrial fibre structures, including the crista terminalis and
septopulmonary bundle (Pashakhanloo et al., 2016; Roney et al.,
2020b). Further work should investigate alternative mechanisms
for PVI response, for example, by reducing the critical mass
of tissue available for fibrillation. The effects of additional
ablation lesions on preferential pathways could be investigated
in future studies.
CONCLUSIONS
Preferential pathways of activation exist during AF. Our novel
technique identified patients that were likely to respond to
PVI during an ablation procedure as those with preferential
activation flow from the PV antra to the LA body. This flow
may correspond to the presence of drivers in the PV regions. We
proposed that themetric should be applied in a prospective study,
with high-density catheter recordings in the PV at the LA-PV
junction, to confirm the relationship between preferential flow,
AF mechanisms, and long-term PVI outcome.
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